BioSpace News Archive

Medivir to participate at the Kempen Life Sciences Conference - Apr 20, 2021

Medivir AB announces that the company will participate at the virtual meeting Kempen Life Sciences Conference - 2021 Thematic Virtual Series, on April 21.

April 20, 2021
·
1 min read
Business

XNK Therapeutics appoints Michael Uhlin as Chief Scientific Officer

XNK Therapeutics AB announced the appointment of Professor Michael Uhlin as Chief Scientific Officer, effective August 1st.

April 20, 2021
·
3 min read
XPhyto adds Top-Level Executive Talent to its Global Operations

XPhyto Therapeutics Corp. is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer of XPhyto and the addition of Mr. Manfred Buchberger as the Head of Corporate Development at XP Diagnostics GmbH, a wholly owned German subsidiary of the Company.

April 20, 2021
·
5 min read
Deals

Forbion Announces Final Close of Forbion Growth Opportunities Fund I at EUR 360 Million (USD 428 Million)

Forbion, a leading European life sciences venture capital firm, announces the final close of its Forbion Growth Opportunities Fund I at the hard cap amount of EUR 360 million.

April 20, 2021
·
5 min read
Business

Tubulis appoints Günter Fingerle-Rowson as Chief Medical Officer to lead the clinical development of its new generation of ADCs

Tubulis announced the appointment of Günter Fingerle-Rowson, MD, PhD, as Chief Medical Officer to complement the leadership team and to further build the company’s clinical expertise.

April 20, 2021
·
3 min read
Genetown

Avacta Receives Clinical Validation of AffiDX SARS-CoV-2 Antigen Lateral Flow Test

Completing the technical data set for self-declaration of a CE mark for professional use in early May, followed immediately by commercial launch in Europe

April 20, 2021
·
3 min read
Business

QIAGEN N.V. to Report First Quarter 2021 Results

QIAGEN N.V. announced that it plans to release its report on results for the first quarter 2021 on Monday, May 3, at approximately 22:05 Central European Time / 16:05 Eastern Daylight Time.

April 20, 2021
·
2 min read
Business

Amarin to Report First Quarter Results and Host Conference Call on April 29, 2021

Amarin Corporation plc announced that it will host a conference call with members of Amarin senior management to discuss the company’s first quarter 2021 financial results and provide an operational update on Thursday, April 29, 2021, at 7:30 a.m. ET.

April 20, 2021
·
3 min read
Business

Aesthetic Medical International Holdings Group Limited Reports Fourth Quarter and Fiscal Year 2020 Unaudited Financial Results

Aesthetic Medical International Holdings Group Limited, a leading provider of aesthetic medical services in China, announces its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2020.

April 20, 2021
·
31 min read
Business

Theravance Biopharma to Report First Quarter 2021 Financial Results on May 4, 2021

Theravance Biopharma, Inc., a diversified biopharmaceutical company primarily focused on the discovery, development and commercialization of organ-selective medicines, will report its first quarter 2021 financial results and provide a business update after market close on Tuesday, May 4, 2021.

April 20, 2021
·
2 min read